Scheiner, “Recombinant allergens: biological, immunological and practical aspects,” Int. Arch. Allergy Immunol. 98:93-96 (1992). |
Secrist, et al., “Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals,” J. Exp. Med. 178: 2123-2130 (1993). |
Shanti, et al. “Identification of tropomyosin as the major shrimp allergen and characterization of its IgE-binding epitopes,” J. Immunol. 151, 5354-5363 (1993). |
Sparholt, et al., “the allergen specific B-cell response during immunotherapy,” Clinical and Experimental Allergy 22: 648-653 (1992). |
Taylor, et al., “Peanut oil is not allergenic to peanut sensitive individuals,” J. Allergy Clin. Immunol. 68: 372-375 (1981). |
Van Der Stoep, et al., In vivo and in vitro IgE isotype switching in human B lymphocytes: evidence for a predominantly direct IgM to IgE class switch program. European J. Immunol 24: 1307-1311 (1994). |
Van Kampen, et al., “Analysis of B-cell epitopes in the N-terminal region of Chi t I component III using monoclonal antibodies,” MolecularImmunol. 31: 1133-1140 (1994). |
Yunginger, et al., “Fatal food-induced anaphylaxis,” JAMA 260: 1450-1452 (1988). |
Burks, et al., “Epitope specificity and immunoaffinity purification of the major peanut allergen, Ara h I,” J Allergy Clin Immunol. 93(4): 743-50 (1994). |
Burks, et al., “Epitope specificity of the major peanut allergen, Ara h II,” J Allergy Clin Immunol. 95(2):607-11. (1995). |
Burks, et al., “Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge,” J Allergy Clin Immunol. 90(6 Pt 1): 962-9 (1992). |
Burks, et al., “Identification of a major peanut allergen Ara h I, in patients with atopic dermatitis and positive peanut challenge,” J. Allergy Clin. Immunol. 88:172-179 (1991). |
Burks, et al., “Identification of peanut agglutinin and soybean trypsin inhibitor as minor legume allergens,” Int Arch Allergy Immunol. 105(2):143-149 (1994). |
Burks, et al., “Isolation, identification, and characterization of clones encoding antigens responsible for peanut hypersensitivity,” Int Arch Allergy Immunol. 107(1-3): 248-50 (1995). |
Elsayed, et al., “Synthetic allergenic epitopes from the amino-terminal regions of the major allergens of hazel and birch pollen,” Int. Arch. Allergy Appl. Immunol. 89: 410-415 (1989). |
Fitzsimmons, et al., “Immunothrapy- definition and mechanism,” Allergy Proc. 11:156 (1990). |
Fung-Leung, et al., “transgneic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranualtion and in allergic reactions,” J. Exp. Med. 183: 49-56 (1996). |
Garcia, et al., “Nonspecific changes in immunotherapy with house dut extract,” J. Invest Alergol. Clin Immunol. 5: 18-24 (1995). |
Aas, et al., “Physico-chemical properties and specific activity of a purified allergen (codfish),” Dev. Biol. Strand. 29: 90-98 (1975). |
Ball, et al., “A major continuous allergenic epitope of bovine beta-lactoglobulin recognized by human IgE binding,” Clin. Exp. Allergy 24: 758-764 (1994). |
Bernhisel-Broadbent, et al., “Cross-allergenicity in the legume botanical family in children with food hypersensitivity. II. Laboratory correlates” J Allergy Clin. Immunol. 84:701-709 (1989). |
Birkner, et al., “Evaluation of immunothrapy-induced changes in specific IgE, IgG, and IgG-subclasses in birch pollen-allergic patient by means of immunoblotting, Correlation with Clinical Response,” Allergy 45: 418-426. |
Bock, et al., “The natural history of peanut allergy,” J. Allergy Clin. Immunol. 83: 900-904 (1989). |
Breiteneder, et al., “Complementary DNA cloning and expression in Escheria coli of Aln g I, the major allergen in pollen odf alder (Alnus glutinosa),” J. Allergy Clin. Immunol. 90:909-917 (1992). |
Burks, “Allergenicity of peanut and soybean extracts altered by chemical or thermal denaturation in patients with atopic dermatitis and positive food challenges,” J Allergy Clin Immunol 90(6 pt 1): 889-97 (1992). |
Burks, et al. “Atopic dermatitis: clinical relevance of food hypersensitivity reactions,” J. Pediatr. 113: 447-451 (1988). |
Burks, et al. “Mapping and mutational analysis of the IgE-binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity,” Eur. J. Biochem. 245: 334-339 (1997). |
Burks, et al. “Recombinant peanut allergen Ara h I expression and IgE binding in patients with peanut hypersensitivity,” J. Clinical Invest. 96: 1715-1721 (1995). |
Gibbs, et al., “Evolution of legume seed storage proteins—a domain common to legumins and vicilins is duplicated in vicilins,” Mol. Biol. Evol. 6: 614-623 (1989). |
Gieni, et al., “Allergen-specific modulation of cytokins synthesis patterns and IgE responses in vivo with chemically modified allergen,” The Journal of Immunol. 150:302-310 (1993). |
Gordon, “Future immunotherapy: what lies ahead?” Otolaryngol Head Neck Surg. 113: 603-605 (1995). |
Herian, et al. “Identification of soybean allergens by immunoblotting with sera from soy-allergic adults,” Int. Arch. Allergy Appl. Immunol. 92: 193-198 (1990). |
Jameson, et al., “The antigenic index: a novel algorithm for predicting antigenic determinants,” Comput. Appl. Biosci. 4: 181-186 (1988). |
Jansen, et al., “Prevalance of food allergy and intolerance in the adult Dutch population,” J. Allergy Clin. Immunol. 93: 446-456 (1994). |
Oppenheimer et al. “Treatment of peanut allergy with rush immunotherapy,” J Allergy Clin Immunol. 90: 256-62 (1992). |
Reisman, “Fifteen years of hymenoptera venom immunotherapy: changing concepts and lessons,” Allergy Proceedings 15: 61-63 (1994). |
Sampson, “The role of food allergy and mediator release in atopic dermatitis,” J. Allergy Clin. Immunol. 81: 635-645 (1988). |
Sampson, et al., “Fatal and near-fatal anaphylactic reactions to food in children and adolescents,” N Engl J Med 327: 380-384 (1992). |